Scope Of Practice — Apply scope of authority vs scope of practice to resolve what a pharmacist may legally do - Mpje

SECTION 1

Historical Context & Motivation

The question of what a pharmacist may legally do has evolved dramatically over more than a century of American pharmacy regulation. In the earliest days of the profession, pharmacists—then called apothecaries—compounded remedies, diagnosed conditions, and dispensed medications with virtually no formal legal constraints. As the pharmaceutical sciences matured and the potential for patient harm became better understood, legislatures began codifying the boundaries of pharmacy practice. The twin concepts of scope of practice and scope of authority emerged as the principal legal tools for drawing these boundaries, and understanding the distinction between them is essential for any pharmacist preparing for the MPJE.

1906 • Pure Food and Drug Act

The first major federal legislation addressing drug safety; it established the principle that the government has authority to regulate drug products, laying groundwork for professional practice standards.

1951 • Durham-Humphrey Amendment

Formally divided drugs into prescription-only and over-the-counter categories, defining when a pharmacist required a prescriber's authorization to dispense—an early codification of scope of authority constraints.

1970s–1990s • State Practice Acts Modernized

State legislatures and boards of pharmacy systematically revised pharmacy practice acts, specifying which clinical activities fell within a pharmacist's scope of practice—such as patient counseling, immunization, and drug therapy management.

2000s–Present • Collaborative Practice & Provider Status Expansion

Many states adopted collaborative practice agreements (CPAs) and provider-status laws, broadening pharmacists' scope of authority to include prescribing under protocol, ordering lab tests, and administering vaccines—reflecting a national trend toward pharmacist-delivered clinical services.

This historical trajectory raises a fundamental question that the MPJE tests repeatedly: when a pharmacist encounters a clinical situation in practice, how does one determine whether a particular action is legally permissible? The answer lies in understanding the interplay between what a pharmacist is trained and competent to do (scope of practice) and what a pharmacist is legally permitted to do under the applicable federal law, state statute, board rule, or institutional policy (scope of authority).

SECTION 2

Core Principles & Definitions

Before analyzing specific scenarios, it is critical to internalize the precise meanings of the two foundational concepts. Although they sound similar and often overlap, scope of practice and scope of authority originate from different sources, serve different purposes, and impose different kinds of limits on professional conduct. A pharmacist who confuses them risks either overstepping legal boundaries or under-serving patients by declining activities that are, in fact, authorized.

Scope of Practice

The full range of activities that a pharmacist is educated, trained, and competent to perform as defined by the profession's standards, accreditation bodies, and state practice acts. It answers the question: What can pharmacists, as a profession, do?

Scope of Authority

The subset of scope-of-practice activities that a specific pharmacist is legally permitted to perform in a given jurisdiction, setting, or situation, based on statutes, board regulations, collaborative practice agreements, or institutional protocols. It answers: What may this pharmacist do here and now?

State Practice Act

The primary state statute that defines the practice of pharmacy in a jurisdiction, establishes licensure requirements, and enumerates permissible and prohibited acts—serving as the legal backbone for both scope of practice and scope of authority.

Collaborative Practice Agreement (CPA)

A formal, written arrangement between a pharmacist and a prescriber that grants the pharmacist authority to perform specified clinical activities—such as modifying drug therapy or ordering labs—that would otherwise exceed the pharmacist's independent scope of authority.

Standard of Care

The degree of care, skill, and judgment that a reasonably competent pharmacist in the same practice setting would exercise. While not a statutory construct, falling below the standard of care can trigger malpractice liability even when the action fell within one's scope of authority.

✦

KEY TAKEAWAY

Think of scope of practice as the entire toolbox that a licensed pharmacist could potentially carry, while scope of authority is the specific set of tools your employer, your state's board, and the applicable law allow you to use on a particular job site. A carpenter may own a welder, but their carpentry license does not authorize welding on a construction project. Similarly, a pharmacist may be competent to prescribe a medication, but unless state law, a CPA, or institutional policy grants that authority, doing so is legally impermissible.

SECTION 3

Visual Explanation — Nested Authority Model

This nested-circle diagram illustrates the fundamental hierarchy: scope of practice (outermost, dashed violet) defines the broadest boundary of professional competence. Within that sits the state scope of authority (cyan), then institutional or CPA authority (pink), and finally the pharmacist's own individual competence (amber). Legal permissibility requires that an activity fall within every concentric circle.

The diagram above captures the single most important analytical framework for MPJE questions about pharmacist activities. When a question asks whether a pharmacist "may" do something, the test-taker should mentally trace through each concentric ring. First, is the activity within the profession's recognized scope of practice? If not, no amount of legal authorization can make it permissible—pharmacists cannot perform surgery, for example, regardless of what a CPA might say. Second, does the specific state's practice act grant authority for that activity? Third, do institutional policies or a CPA further refine or restrict that authority? Finally, has the individual pharmacist acquired the necessary training and credentials? Only when the answer to every layer is affirmative is the activity legally defensible.

SECTION 4

How Scope of Practice and Scope of Authority Interact

The Decision Algorithm

Although pharmacy jurisprudence does not rely on mathematical equations, the relationship between scope of practice and scope of authority can be expressed as a logical decision framework. Think of it as an algorithm with sequential gates: each gate must be passed before the pharmacist is authorized to act. This section presents that decision logic and then examines the primary legal sources that feed into each gate.

This decision flowchart shows the five sequential gates a pharmacist must pass. An activity is legally permitted only when it satisfies all five conditions: it falls within the profession's recognized scope of practice, is authorized by the applicable state law and board rules, is covered by any required collaborative practice agreement or institutional protocol, the pharmacist possesses individual competence, and the action meets the standard of care.

Sources of Legal Authority

The legal authority for pharmacist activities is drawn from a layered hierarchy. At the federal level, statutes such as the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Controlled Substances Act (CSA) set baseline requirements that no state may undercut—such as DEA registration for handling controlled substances. State pharmacy practice acts build upon these federal floors, sometimes granting broader authority (e.g., allowing pharmacists to prescribe naloxone without a physician's order) and sometimes imposing tighter constraints. Below the statutory layer, boards of pharmacy issue administrative rules and guidance documents that interpret and operationalize the practice act. At the institutional level, employer policies and collaborative practice agreements may further narrow the pharmacist's authority. The essential principle to remember is the most restrictive rule governs: when federal law, state law, and institutional policy each address the same activity, the pharmacist must comply with whichever standard is most stringent.

⚠

MPJE Testing Principle

When a question describes a conflict between federal and state law, apply the stricter standard. For example, if federal law requires a prescription for a certain drug, but a state law allows pharmacist dispensing without one, the pharmacist must still require the prescription. Conversely, if a state is more restrictive than federal law, the state law controls within that jurisdiction.

SECTION 5

Classifying Pharmacist Activities by Authority Type

Not all pharmacist activities require the same type of authorization. Some are universally within the pharmacist's independent scope of authority in every state, while others require specific legal enablers. The following table classifies common pharmacist activities according to the type of authority typically required. Note that specific requirements vary by jurisdiction, and MPJE candidates must know the rules for the state in which they are testing.

Activity	Authority Type	Typical Legal Source
Dispensing a valid prescription	Independent authority	State practice act; federal DSCSA requirements
Patient counseling	Independent authority	State practice act; OBRA '90 (Medicaid patients)
Therapeutic substitution (generic)	Independent authority	State substitution laws; Orange Book ratings
Administering immunizations	State-authorized (may require certification)	State practice act; PREP Act (federal emergency); APhA certification
Prescribing under protocol (e.g., hormonal contraceptives)	CPA / Protocol-dependent authority	State CPA statute; statewide standing order or protocol
Modifying drug therapy (dose adjustment)	CPA / Protocol-dependent authority	CPA with prescriber; institutional P&T committee protocol
Ordering and interpreting lab tests	CPA / Protocol-dependent authority	State practice act (if authorized); CPA or institutional privilege
Independently diagnosing a medical condition	Outside scope of practice	Medical practice act (physician/NP scope); not authorized for pharmacists
Performing surgery or invasive procedures	Outside scope of practice	Medical/surgical practice act; no pharmacy legal authority

Common pharmacist activities classified by the type and source of legal authority required.

The table above reveals a critical pattern. Activities in the green (independent authority) category are universally considered part of pharmacy practice and are authorized by every state's practice act. Activities in cyan (state-authorized) are within scope of practice but may require additional certification, training, or state-specific authorization. Activities in pink (CPA/protocol-dependent) are clearly within a pharmacist's clinical competence but require a formal collaborative arrangement to confer legal authority. Activities in red (outside scope of practice) are beyond the boundaries of pharmacy entirely, and no CPA or state law can authorize a pharmacist to perform them.

SECTION 6

Worked Example — Applying the Framework

Consider the following scenario, which is representative of MPJE-style questions: A pharmacist working in a community pharmacy in State X receives a call from a patient with diabetes who reports consistently elevated fasting blood glucose levels. The pharmacist has a collaborative practice agreement with the patient's physician that authorizes the pharmacist to adjust insulin dosages based on blood glucose readings. The patient asks the pharmacist to increase the insulin dose. May the pharmacist legally do so?

Scenario Analysis: Insulin Dose Adjustment Under a CPA

1
Step 1 — Identify the Proposed Activity

The proposed activity is modifying drug therapy—specifically, adjusting the dose of insulin for a diabetic patient based on clinical data (blood glucose readings).
2
Step 2 — Gate 1: Scope of Practice

Is adjusting drug therapy within the pharmacist profession's recognized scope of practice? Yes. Clinical pharmacy training includes pharmacokinetic dosing, drug therapy management, and therapeutic adjustments. The American College of Clinical Pharmacy and ACPE accreditation standards recognize drug therapy management as a core pharmacist competency.

✓ Passes Gate 1
3
Step 3 — Gate 2: State Scope of Authority

Does State X's practice act authorize pharmacists to modify drug therapy? We must check whether the state permits collaborative practice agreements that include drug therapy adjustment. In this scenario, State X has a CPA statute that allows pharmacists, under a written protocol with a physician, to initiate, modify, or discontinue drug therapy. The state practice act therefore provides the legal framework for this activity.

✓ Passes Gate 2
4
Step 4 — Gate 3: CPA / Institutional Authority

Does the specific CPA between this pharmacist and the physician cover insulin dose adjustments? Yes—the scenario states that the CPA "authorizes the pharmacist to adjust insulin dosages based on blood glucose readings." The activity is explicitly within the scope of the agreement. Had the CPA been limited to, say, statin therapy adjustments, insulin dose modification would not be authorized even though it is within the pharmacist's scope of practice and the state's legal framework.

✓ Passes Gate 3
5
Step 5 — Gate 4: Individual Competence

Has this specific pharmacist received training in diabetes management and insulin dosing? The question does not suggest otherwise, and the existence of the CPA implies the collaborating physician has vetted the pharmacist's competence. We assume this gate is satisfied.

✓ Passes Gate 4
6
Step 6 — Gate 5: Standard of Care

Would a reasonably competent pharmacist in the same setting, with the same CPA, make a dose adjustment based on the patient's reported blood glucose data? Yes, provided the pharmacist follows evidence-based guidelines (e.g., ADA Standards of Medical Care in Diabetes), documents the intervention, and communicates with the prescriber as required by the CPA.

✓ Passes Gate 5 — Activity is LEGALLY PERMITTED

💡

What Would Change the Answer?

If State X did not have a CPA statute, the pharmacist would fail at Gate 2—the activity would be within scope of practice but outside scope of authority. If the CPA existed but covered only warfarin, not insulin, the pharmacist would fail at Gate 3. If the pharmacist had never received diabetes management training, Gate 4 would fail. Each gate is independent and must be analyzed separately.

SECTION 7

Scope of Practice vs. Scope of Authority — Side-by-Side Comparison

The distinction between scope of practice and scope of authority is subtle but consequential. The following table highlights the key differences across multiple dimensions that MPJE candidates should internalize.

Dimension	Scope of Practice	Scope of Authority
Definition	The full range of activities the profession is trained and competent to perform	The subset of those activities a specific pharmacist is legally permitted to perform in a given context
Source	Professional education standards, accreditation bodies (ACPE), and professional organizations	Federal and state statutes, board of pharmacy regulations, CPAs, institutional policies
Variability	Relatively uniform across the U.S. (national education standards)	Highly variable by state, practice setting, and individual agreements
Can it change?	Evolves slowly as pharmacy education and professional standards change	Can change rapidly through new legislation, emergency orders, or CPA modifications
Consequence of exceeding	Practicing outside one's profession entirely (e.g., performing surgery); may constitute criminal practice of medicine	Unauthorized practice of pharmacy or violation of board rules; may result in license discipline, fines, or criminal charges
Relationship	Always ≥ scope of authority (the outer circle)	Always ≤ scope of practice (an inner circle)

Key distinctions between scope of practice and scope of authority relevant to the MPJE.

✦

KEY TAKEAWAY

Think of scope of practice as the ceiling set by the profession's knowledge base and scope of authority as the floor plan drawn by the law. A pharmacist can never build higher than the ceiling (you cannot perform activities outside your profession's scope), but within that ceiling, the rooms you can enter are defined by which doors the law has unlocked for you. Moving to a new state is like moving to a new building—the ceiling height may be similar, but the floor plan can be entirely different.

SECTION 8

Connection to Advanced Regulatory Concepts

The scope of practice versus scope of authority framework does not exist in isolation. It connects to several advanced regulatory and legal concepts that MPJE candidates should recognize. Understanding these connections deepens one's ability to analyze complex scenarios involving pharmacist liability, emerging practice models, and multistate practice.

Core Concept	Advanced Extension	Connection to Scope Analysis
Scope of authority (state-specific)	PREP Act emergency declarations	During public health emergencies, federal declarations can temporarily expand pharmacist scope of authority nationwide—overriding restrictive state laws (e.g., COVID-19 vaccine administration by pharmacists in states that previously did not permit it).
CPA-dependent authority	Statewide standing orders	Some states issue statewide protocols or standing orders (e.g., for naloxone or hormonal contraceptives) that function as a universal CPA, granting authority to all qualified pharmacists without requiring individual physician agreements.
Individual competence gate	Board-mandated specialty credentials	Boards may require specific certifications (e.g., APhA immunization certificate, Board Certified Pharmacotherapy Specialist) before granting authority for certain activities—linking the competence gate to a formal credentialing requirement.
Standard of care	Malpractice and negligence liability	Even when an activity falls within both scope of practice and scope of authority, performing it negligently exposes the pharmacist to civil liability. A malpractice claim evaluates whether the pharmacist met the professional standard of care—a separate legal analysis from whether the activity was authorized.

How the basic scope framework connects to advanced MPJE regulatory concepts.

Looking forward, the trend in American pharmacy regulation is toward progressive expansion of pharmacist scope of authority to match an already broad scope of practice. The 2020–2024 COVID-19 pandemic demonstrated this dynamic vividly: pharmacists were already trained to test, triage, and vaccinate, but many states had not granted the legal authority to do so. Federal emergency declarations and subsequent state legislative action closed that gap rapidly. MPJE candidates should expect questions that test the ability to distinguish between what a pharmacist can do (competence) and what a pharmacist may do (authority), especially in states that are actively expanding pharmacist roles.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A pharmacist holds a PharmD degree and completed residency training in ambulatory care, which included extensive education in point-of-care testing and diabetes management. The pharmacist's state practice act does not include pharmacist-administered point-of-care testing within the definition of the practice of pharmacy. Is the pharmacist legally permitted to perform a fingerstick A1C test on a patient in the community pharmacy? Explain why or why not, using the distinction between scope of practice and scope of authority.

Show answer

No, the pharmacist is not legally permitted to perform the A1C test in this scenario. While point-of-care testing falls within the pharmacist's scope of practice—the profession recognizes it as a clinical competency, and this pharmacist has specific residency training—the state practice act does not authorize pharmacists to perform point-of-care testing. Scope of authority is the controlling factor: without explicit statutory or regulatory authorization, performing the test would constitute an unauthorized activity. The pharmacist could advocate for legislative change or seek a CPA that might authorize the testing if the state's CPA statute is broad enough, but absent that authority, competence alone does not confer legal permission.

Question 2: BASIC CALCULATION

A pharmacist in State Y has a collaborative practice agreement with a physician to manage warfarin therapy. The CPA specifies that the pharmacist may adjust warfarin doses by no more than ±2 mg per week based on INR results. The patient's current dose is 5 mg daily, and the most recent INR is 3.8 (goal range 2.0–3.0). According to the pharmacist's clinical judgment and institutional protocol, a dose reduction of 1.5 mg daily is appropriate. Is this dose change within the pharmacist's scope of authority?

Show answer

We must examine whether the proposed change falls within the CPA's specified parameters. The CPA limits adjustments to ±2 mg per week. A reduction of 1.5 mg per day would translate to a weekly reduction of 10.5 mg (1.5 mg × 7 days), which substantially exceeds the 2 mg weekly limit specified in the CPA. Therefore, even though the dose reduction may be clinically appropriate and within the pharmacist's scope of practice (drug therapy management), it exceeds the specific scope of authority granted by the CPA. The pharmacist must either contact the physician for a direct order to make this larger adjustment or make a smaller adjustment within the CPA's parameters—such as reducing the daily dose by approximately 0.25 mg to stay within the 2 mg/week boundary—and then reassess.

Question 3: INTERMEDIATE

A pharmacist practices in a state where pharmacists are authorized by statute to prescribe and dispense hormonal contraceptives under a statewide standing order. A 22-year-old patient requests oral contraceptives. The pharmacist completes the required risk assessment and determines the patient is eligible. However, the pharmacist's employer—a national chain pharmacy—has a corporate policy stating that pharmacists in this chain may not prescribe any medications, including those authorized by statewide standing orders. May the pharmacist prescribe the contraceptive? Analyze using all relevant layers of authority.

Show answer

This scenario illustrates a conflict between state-granted authority and institutional policy. Gate 1 (scope of practice): Prescribing hormonal contraceptives is within the pharmacist profession's recognized scope of practice. Gate 2 (state authority): The state has specifically authorized this activity through a statewide standing order. Gate 3 (institutional authority): The employer's corporate policy prohibits pharmacist prescribing. Although the pharmacist has both the professional competence and the state's legal authorization, the employer's policy restricts the pharmacist's scope of authority within that practice setting. The pharmacist working for this chain may not prescribe the contraceptive while on duty for that employer, because institutional policies can further narrow (though not expand) scope of authority. The pharmacist could refer the patient to another pharmacy, could advocate internally for a policy change, or could potentially prescribe if practicing in a different setting (e.g., moonlighting at an independent pharmacy). This underscores the principle that scope of authority is context-dependent.

Question 4: APPLIED

During a declared public health emergency for a novel respiratory virus, the U.S. Secretary of Health and Human Services issues a PREP Act declaration authorizing pharmacists to order and administer FDA-authorized diagnostic tests for the virus. A pharmacist in a state whose practice act does not independently authorize pharmacist-ordered testing decides to begin offering rapid antigen testing at the community pharmacy. A colleague argues that the pharmacist is exceeding state scope of authority. Who is correct, and what legal principle resolves the conflict?

Show answer

The pharmacist is correct. The PREP Act is a federal statute that, when invoked by the HHS Secretary, preempts conflicting state laws and grants covered persons (including pharmacists) legal authority to administer or use covered countermeasures. Under the Supremacy Clause of the U.S. Constitution, federal law preempts state law when the two conflict, provided Congress has authority to legislate in that area (public health emergencies qualify under the Commerce Clause). Therefore, the PREP Act declaration effectively expands the pharmacist's scope of authority at the federal level, overriding the state practice act's silence or prohibition on pharmacist-ordered testing during the emergency period. Once the declaration expires, the pharmacist's authority reverts to whatever the state law permits. This is a prime example of how scope of authority—unlike scope of practice—can change rapidly through legal action.

Question 5: CRITICAL THINKING

A pharmacist holds a Board Certified Pharmacotherapy Specialist (BCPS) credential and works in a hospital with a comprehensive CPA that authorizes pharmacist-driven anticoagulation management. The pharmacist identifies that a patient on heparin has developed heparin-induced thrombocytopenia (HIT), a life-threatening condition requiring immediate discontinuation of heparin and initiation of an alternative anticoagulant. The CPA does not specifically address HIT management, and the attending physician cannot be reached. Analyze whether the pharmacist can (a) discontinue heparin and (b) initiate argatroban, and discuss the interplay between scope of practice, scope of authority, standard of care, and the duty to prevent patient harm.

Show answer

This is a nuanced scenario requiring balance between legal authority and ethical obligation. (a) Discontinuing heparin: Most state practice acts and institutional policies grant pharmacists the authority—and indeed the professional duty—to withhold or discontinue a medication when continuing it poses imminent, serious harm to the patient. The standard of care demands that any healthcare professional who recognizes HIT should stop the offending agent immediately. Even if the CPA does not specifically address HIT, a pharmacist's independent professional judgment and the duty to prevent foreseeable harm likely provide sufficient legal and ethical justification for stopping heparin. This action falls comfortably within scope of practice and, arguably, within the pharmacist's independent scope of authority. (b) Initiating argatroban: This is more complex. Initiating a new medication generally constitutes prescribing, and unless the CPA or an institutional protocol explicitly authorizes the pharmacist to initiate alternative anticoagulants, doing so may exceed the pharmacist's scope of authority. The pharmacist should attempt to reach the physician or an alternative prescriber immediately. If truly no prescriber is available and the patient's life is in imminent danger, the pharmacist may invoke a 'necessity' or 'emergency' justification, which many state practice acts recognize implicitly or explicitly. The pharmacist should document the clinical rationale thoroughly, as any post-hoc review will assess whether the action met the standard of care and was proportionate to the emergency. This scenario illustrates that scope of authority analysis is not always black-and-white; life-threatening emergencies may invoke exceptions that the law recognizes, but the pharmacist bears the burden of demonstrating that the circumstances warranted the action.

SUMMARY

Lesson Summary

Summary

The distinction between scope of practice and scope of authority is foundational to pharmacy jurisprudence and is heavily tested on the MPJE. Scope of practice defines what the pharmacy profession as a whole is trained and competent to do, while scope of authority defines what a specific pharmacist in a specific jurisdiction and setting is legally permitted to do. Scope of authority is always a subset of scope of practice and is shaped by federal law, state practice acts, board of pharmacy regulations, collaborative practice agreements, and institutional policies. When these sources conflict, the most restrictive standard governs.

To determine whether a pharmacist may legally perform any given activity, apply the five-gate decision framework: (1) Is the activity within the profession's recognized scope of practice? (2) Does the state's practice act and board rules authorize it? (3) Do any required CPAs or institutional protocols cover it? (4) Does the pharmacist possess individual competence? (5) Is the action consistent with the standard of care? Only when every gate is satisfied is the activity legally defensible. Remember that the trend in pharmacy regulation is toward expanding scope of authority to match a broad scope of practice, but the expansion is uneven across states—making jurisdiction-specific knowledge essential for the MPJE.